Committee MemberEmploymentConsultantSpeakers BureauOwnership/Partnership/PrincipalPersonal ResearchInstitutional/Organizational or Other Financial BenefitExpert Witness
Mariell Jessup (Chair)Leducq Corporation—Chief Scientific OfficerNoneNoneNoneNoneNoneNone
Mark H. Drazner (Vice Chair)University of Texas Southwestern Medical Center—Professor, Internal MedicineNoneNone
  • Trevena

None
  • St. Jude Medical

None
Wendy BookEmory Healthcare—Director, Emory Adult Congenital Heart CenterNoneNoneNone
  • Actelion

NoneNone
Joseph C. Cleveland, Jr.University of Colorado—Surgical Director, Cardiac Transplantation and Mechanical Circulatory Support; Professor of SurgeryNoneNoneNone
  • HeartWare

  • St. Jude Medical

NoneNone
Ira DauberCentura Heart Colorado—Medical Director for Heart Failure; South Denver Cardiology Heart Center—Medical Director for Heart Failure; University of Colorado—Associate Clinical Professor of MedicineNoneNoneNoneNoneNoneNone
Susan FarkasSanford Heart and Vascular Center—Director of Echocardiography; University of North Dakota SMHS—Clinical Associate Professor of MedicineNoneNoneNoneNoneNoneNone
Mahazarin GinwallaUniversity Hospitals Cleveland Medical Center—Medical Director of Heart Failure; Assistant Professor of MedicineNoneNoneNoneNoneNoneNone
Jason N. KatzUniversity of North Carolina School of Medicine—Divisions of Cardiology and Pulmonary/Critical Care Medicine; Director, Mechanical Heart Program; Director, Cardiac Intensive Care Unit; Director, Cardiovascular & Thoracic Surgical Intensive Care Unit and Critical Care Service; Director, Cardiovascular Clinical Trials; Associate Professor of MedicineNoneNoneNone
  • Thoratec

NoneNone
Peggy KirkwoodMission Hospital—Cardiovascular and Palliative Care Nurse PractitionerNoneNoneNoneNoneNoneNone
Michelle M. KittlesonCedars-Sinai Heart Institute—Director, Heart Failure Research; Director, Post-Graduate Education in Heart Failure and Transplantation; Associate Professor of MedicineNoneNoneNoneNoneNoneNone
Joseph E. MarineJohns Hopkins University School of Medicine—Vice-Director, Division of Cardiology; Associate Professor of MedicineNoneNoneNoneNoneNoneNone
Paul MatherPerelman School of Medicine, University of Pennsylvania—Professor of Clinical Medicine Heart Failure–Transplant ProgramNoneNoneNoneNoneNoneNone
Alanna A. MorrisEmory University—Assistant Professor
  • Novartis

NoneNoneNoneNoneNone
Donna M. PolkBrigham and Women's Hospital—Director, Cardiovascular FellowshipNoneNoneNoneNoneNoneNone
Antoine SakrLoma Linda University Medical Center, Department of Cardiology—Co-Director, Advanced Heart Failure and Transplant; Assistant Professor of MedicineNoneNoneNoneNoneNoneNone
Kelly H. SchlendorfVanderbilt Heart and Vascular Institute—Co-Director, Advanced HF/Transplant Training Program; Assistant Professor in MedicineNoneNoneNoneNoneNoneNone
Esther E. VorovichNorthwestern University Feinberg School of Medicine—Assistant Professor in Medicine–Cardiology
  • Argon Medical

  • Plexus

NoneNoneNone
  • Rex Medical

None

This table represents the relationships of committee members with industry and other entities that were determined to be relevant to this document. These relationships were reviewed and updated in conjunction with all conference calls of the writing committee during the document development process. The table does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of ≥5% of the voting stock or share of the business entity, or ownership of ≥$10,000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person’s gross income for the previous year. Relationships that exist with no financial benefit are also included for the purpose of transparency. Relationships in this table are modest unless otherwise noted. Please refer to http://www.acc.org/guidelines/about-guidelines-and-clinical-documents/relationships-with-industry-policy for definitions of disclosure categories or additional information about the ACCF Disclosure Policy for Writing Committees. Please refer to http://jaccjacc.acc.org/Clinical_Document/AHFTC_ATS_Author_Comprehensive_Disclosure_Table.pdf for a list of corresponding comprehensive healthcare-related disclosures for each author.

ABIM = American Board of Internal Medicine; ACC = American College of Cardiology; ACP = American College of Physicians; AHA = American Heart Association; APFED = American Partnership for Eosinophilic Disorders; CDC = Centers for Disease Control and Prevention; HFSA = Heart Failure Society of America; ISHLT = The International Society for Heart & Lung Transplantation; NHLBI = National Heart, Lung, and Blood Institute; and NIH = National Institutes of Health.

  • Dr. Jessup was employed by University of Pennsylvania School of Medicine as a Professor of Medicine during most of the writing effort.

  • Significant relationship.

  • Dr. Mather was employed by Jefferson Heart Institute as Director, Advanced Heart Failure and by the Sidney Kimmel Medical College of Thomas Jefferson University as the Lubert Family Professor of Cardiology during most of the writing effort.